Debra Yu - Oct 29, 2021 Form 3 Insider Report for LianBio (LIAN)

Role
President & Chief Strategy Officer Exhibit List: Exhibit 24 - Power of Attorney
Signature
By /s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
Oct 29, 2021
Transactions value $
$0
Form type
3
Date filed
10/29/2021, 06:15 PM
Previous filing
Jul 12, 2021
Next filing
Nov 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIAN Stock Option (Right to Buy) Oct 29, 2021 Ordinary Shares 2M $1.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

President & Chief Strategy Officer Exhibit List: Exhibit 24 - Power of Attorney